Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.

PURPOSE: Accurate assessment of cerebral perfusion in moyamoya disease is necessary to determine the indication for treatment. We aimed to investigate the usefulness of dynamic PCASL using a variable TR scheme with optimized background suppression in the evaluation of cerebral perfusion in moyamoya disease. METHODS: We retrospectively analyzed the images of 24 patients (6 men and 18 women, mean age 31.4 ± 18.2 years) with moyamoya disease; each of whom was imaged with both dynamic PCASL using the variable-TR scheme and 123IMP SPECT with acetazolamide challenge. ASL dynamic data at 10 phases are acquired by changing the LD and PLD. The background suppression timing was optimized for each phase. CBF and ATT were measured with ASL, and CBF and CVR to an acetazolamide challenge were measured with SPECT. RESULTS: A significant moderate correlation was found between the CBF measured by dynamic PCASL and that by SPECT (r = 0.53, P < 0.001). The CBF measured by dynamic PCASL (52.5 ± 13.3 ml/100 mg/min) was significantly higher than that measured by SPECT (43.0 ± 12.6 ml/100 mg/min, P < 0.001). The ATT measured by dynamic PCASL showed a significant correlation with the CVR measured by SPECT (r = 0.44, P < 0.001). ATT was significantly longer in areas where the CVR was impaired (CVR < 18.4%, ATT = 1812 ± 353 ms) than in areas where it was preserved (CVR > 18.4%, ATT = 1301 ± 437 ms, P < 0.001). The ROC analysis showed a moderate accuracy (AUC = 0.807, sensitivity = 87.7%, specificity = 70.4%) when the cutoff value of ATT was set at 1518 ms. CONCLUSION: Dynamic PCASL using this scheme was found to be useful for assessing cerebral perfusion in moyamoya disease.

T1ρ mapping improvement using stretched-type adiabatic locking pulses for assessment of human liver function at 3T.

PURPOSE: The purpose of this study is to investigate the performance of stretched-type adiabatic spin lock pulses for homogeneous spin locking with a flexible spin lock time (TSL) setting. METHODS: T1ρ values were obtained from 61 patients and five normal volunteers who were categorized using the Child-Pugh classification and scanned using each spin lock pulse type. The pulses used were the block and two kinds of hyperbolic secant (HS); HS8_10, and HS8_5. Visual scoring was categorized using a four point scale (1:Severe, 2:Moderate, 3:Mild and 4:None) to evaluate the homogeneity of the T1ρ map and the source images obtained by each spin lock pulse. Mean T1ρ values among the patient groups with different Child-Pugh classification were compared. RESULTS: The visual assessment scores were 1.98 ± 1.05 for block pulse locking, 3.87 ± 0.39 for HS8_10 pulse locking, and 3.83 ± 0.45 for HS8_5 pulse locking, respectively. The scores between block pulse and HS8_10 were significantly different (p < 0.001), as were those between block pulse and HS8_5 (p < 0.001). The median T1ρ values of normal liver function, Child-Pugh A, and Child-Pugh B or C were 37.00 ms, 40.77 ms, and 42.20 ms for block pulse, 46.75 ms, 50.78 ms, and 55.60 ms for HS8_10, and 48.80 ms, 55.42 ms, and 57.80 ms for HS8_5, respectively. CONCLUSION: The spin locking sequence using stretched-type adiabatic pulses provides homogeneous liver T1ρ maps with reduced artifact and is necessary for a robust evaluation of liver function using T1ρ.

Assessment of improved motion-sensitized driven equilibrium (iMSDE) for multi-contrast vessel wall screening.

PURPOSE: We assessed the improved motion-sensitized driven equilibrium (iMSDE) technique for multiple contrast 3-dimensional vessel wall imaging at 3T. METHODS: Carotid images were obtained using iMSDE combined with turbo field echo (iMSDE-TFE) and conventional double inversion-recovery turbo spin-echo (DIR-TSE) in 5 healthy adult subjects. The tissue signal-to-noise efficiency (SNReff), SNR divided by the square root of scan time, lumen-tissue contrast-to-noise efficiency (CNReff), CNR divided by the square root of scan time, and tissue signal intensity ratio (SIR) were measured in both techniques and compared. RESULTS: The iMSDE-TFE had higher SNReff and CNReff (P < 0.01) and strong correlation in SIR (R = 0.92) compared to DIR-TSE. CONCLUSION: The iMSDE-TFE sequence is an efficient technique for vessel wall screening.

Intravoxel incoherent motion imaging of masticatory muscles: pilot study for the assessment of perfusion and diffusion during clenching.

OBJECTIVE: The purpose of this study was to evaluate intravoxel incoherent motion (IVIM) imaging for assessing perfusion and diffusion of masticatory muscles during clenching. SUBJECTS AND METHODS: A prospective study was performed to assess the perfusion and diffusion of masticatory muscles during clenching. The masseter and medial pterygoid muscles participate in clenching, and the lateral pterygoids do not. IVIM parameters (microvascular volume fraction, f; pure diffusion coefficient, D; and perfusion-related incoherent microcirculation, D*) were determined on both the clenching and the balancing sides in 24 volunteers. The Wilcoxon test was used to compare the IVIM parameters at rest and during clenching. RESULTS: The f and D* values of the masseters significantly increased on the clenching side (f = 0.17 ± 0.10 vs 0.29 ± 0.11, p < 0.001; D* = 21.3 ± 18.5 × 10(-3) mm(2)/s vs 42.1 ± 33.3 × 10(-3) mm(2)/s, p = 0.0008). However, the D values did not change during clenching (1.26 ± 0.23 × 10(-3) mm(2) vs 1.21 ± 0.35 × 10(-3) mm(2)). The f values of the medial pterygoids also increased on the clenching side (0.20 ± 0.09 vs 0.30 ± 0.09, p < 0.001). On the balancing side, the f values of the masseters (0.19 ± 0.12 vs 0.30 ± 0.12, p < 0.001) and medial pterygoids (0.20 ± 0.09 vs 0.29 ± 0.11, p = 0.0007) significantly increased during clenching. In contrast, the IVIM values of the lateral pterygoids did not change. CONCLUSION: IVIM imaging may be useful for assessing perfusion and diffusion of the masticatory muscles.

Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients.

PURPOSE: To evaluate the utility of pulmonary magnetic resonance (MR) imaging with ultra-short echo times (UTEs) at a 3.0 T MR system for pulmonary functional loss and disease severity assessments of connective tissue disease (CTD) patients with interstitial lung disease (ILD). MATERIALS AND METHODS: This prospective study was approved by the institutional review board, and written informed consent was obtained from 18 CTD patients (eight men and ten women) and eight normal subjects with suspected chest disease (three men and five women). All subjects underwent thin-section MDCT, pulmonary MR imaging with UTEs, pulmonary function test and serum KL-6. Regional T2 maps were generated from each MR data set, and mean T2 values were determined from ROI measurements. From each thin-section MDCT data set, CT-based disease severity was evaluated with a visual scoring system. Mean T2 values for normal and CTD subjects were statistically compared by using Student's t-test. To assess capability for pulmonary functional loss and disease severity assessments, mean T2 values were statistically correlated with pulmonary functional parameters, serum KL-6 and CT-based disease severity. RESULTS: Mean T2 values for normal and CTD subjects were significantly different (p=0.0019) and showed significant correlations with %VC, %DLCO, serum KL-6 and CT-based disease severity of CTD patients (p<0.05). CONCLUSION: Pulmonary MR imaging with UTEs is useful for pulmonary functional loss and disease severity assessments of CTD patients with ILD.

Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.

PURPOSE: To prospectively evaluate the intravoxel incoherent motion (IVIM) parameters (microvascular volume fraction, f; pure diffusion coefficient, D; and perfusion-related incoherent microcirculation, D*) for differentiating between benign and malignant salivary gland tumors. MATERIALS AND METHODS: All participants in this prospective institutional review board-approved study provided written informed consent. The perfusion and diffusion of 20 (65%) benign (12 pleomorphic adenomas and eight Warthin tumors) and 11 (35%) malignant salivary gland tumors were assessed on the basis of the IVIM theory. Diffusion-weighted magnetic resonance imaging was performed by using 11 b values (0-800 sec/mm(2)). The IVIM parameters of the salivary gland tumors were determined by a radiologist, and significant differences between the tumor types were assessed by using the Steel-Dwass test. RESULTS: The f values of Warthin tumors (0.156 ± 0.039 [standard deviation]) were significantly larger than those of pleomorphic adenomas (0.066 ± 0.031) (P = .003). The D values of malignant tumors (0.96 × 10(-3) mm(2)/sec ± 0.22) were significantly different from those of benign tumors (pleomorphic adenomas, 1.38 × 10(-3) mm(2)/sec ± 0.30 [P = .002]; Warthin tumors, 0.61 × 10(-3) mm(2)/sec ± 0.11 [P = .005]). The D* values of malignant tumors (21.99 × 10(-3) mm(2)/sec ± 19.01) were significantly smaller than those of Warthin tumors (42.64 × 10(-3) mm(2)/sec ± 20.17) (P = .022). The combination of D and D* criteria provided the best diagnostic accuracy (100%) for differentiation among the three tumor types. CONCLUSION: IVIM imaging may be helpful for differentiation between benign and malignant salivary gland tumors.

T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.

OBJECTIVE: The purpose of this study was to determine the usefulness of MRI with ultrashort TEs on a 3-T system and of thin-section MDCT for pulmonary function assessment and clinical stage classification of chronic obstructive pulmonary disease (COPD) in smokers. SUBJECTS AND METHODS: Forty smokers (24 men and 16 women; mean age ± SD, 68.0 ± 9.3 years) underwent MRI with ultrashort TEs and thin-section MDCT. Pulmonary function testing was also performed to determine the following: the ratio of forced expiratory volume in 1 second to forced vital capacity (percentage predicted) (FEV(1/)FVC%), percentage predicted forced expiratory volume in 1 second (%FEV(1)), and percentage predicted diffusing capacity of lung for carbon monoxide corrected for alveolar volume (%DLCO/V(A)). All subjects were classified into one of four groups as follows: smokers without COPD, with mild COPD, with moderate COPD, and with severe or very severe COPD. T2(*) maps were expressed using proprietary software. Regional T2(*) values were determined by region of interest measurements and were averaged to determine a mean T2(*) value for each subject. CT-based functional lung volume and the ratio of the wall area to the total airway area were also determined. All indexes were statistically correlated with pulmonary function parameters. Then, all indexes were compared among all groups by means of Tukey's honest significance test. RESULTS: All indexes had significant correlation with FEV(1)/FVC%, %FEV(1), and % DLCO/V(A) (p < 0.05). All indexes except WA% of smokers without COPD and smokers with mild COPD differed significantly from those of smokers with moderate COPD and smokers with severe or very severe COPD (p < 0.05). Moreover, the mean T2(*) value of the moderate COPD group was significantly different from that of the severe or very severe COPD group (p < 0.05). CONCLUSION: MRI with ultrashort TEs is potentially as useful as quantitatively assessed MDCT for pulmonary function loss assessment and clinical stage classification of COPD in smokers.

Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography.

This study had institutional review board approval, and all patients gave informed consent. The purpose of this study was to prospectively evaluate the use of whole-heart three-dimensional (3D) coronary magnetic resonance (MR) angiography in patients suspected of having coronary artery disease. Whole-heart coronary MR angiography was performed in 39 patients (30 men and nine women; mean age, 63.9 years +/- 15.6 [standard deviation]) by using a steady-state free precession sequence with free breathing. Twenty patients (16 men and four women; mean age, 64.9 years +/- 11.7) also underwent conventional coronary angiography. MR angiography was successfully completed in 34 of 39 patients (87%); the average imaging time was 13.8 minutes +/- 3.8. Sensitivity and specificity of MR angiography for detecting significant stenosis were 82% (14 of 17 arteries) and 91% (39 of 43 arteries), respectively. Whole-heart coronary MR angiography with a navigator-gated steady-state sequence can enable reliable 3D visualization of the coronary arteries in patients suspected of having coronary artery disease.